Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC - New York Stock Exchange, Inc. - US09624H2085 - Common Stock - Currency: USD

83.87  -2.69 (-3.11%)

After market: 83.87 0 (0%)

Fundamental Rating

4

Taking everything into account, BXC scores 4 out of 10 in our fundamental rating. BXC was compared to 48 industry peers in the Trading Companies & Distributors industry. BXC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BXC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BXC had positive earnings in the past year.
In the past year BXC had a positive cash flow from operations.
In the past 5 years BXC has always been profitable.
In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

BXC's Return On Assets of 2.33% is in line compared to the rest of the industry. BXC outperforms 45.83% of its industry peers.
With a Return On Equity value of 5.99%, BXC is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
BXC's Return On Invested Capital of 3.48% is on the low side compared to the rest of the industry. BXC is outperformed by 70.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BXC is in line with the industry average of 9.62%.
The 3 year average ROIC (11.45%) for BXC is well above the current ROIC(3.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.33%
ROE 5.99%
ROIC 3.48%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.89%
ROIC(3y)11.45%
ROIC(5y)14.38%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

BXC has a worse Profit Margin (1.30%) than 66.67% of its industry peers.
BXC's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.39%, BXC is not doing good in the industry: 72.92% of the companies in the same industry are doing better.
BXC's Operating Margin has improved in the last couple of years.
The Gross Margin of BXC (16.10%) is worse than 89.58% of its industry peers.
In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 2.39%
PM (TTM) 1.3%
GM 16.1%
OM growth 3Y-33.49%
OM growth 5Y28.67%
PM growth 3Y-36.23%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

7

2. Health

2.1 Basic Checks

BXC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BXC has less shares outstanding than it did 1 year ago.
BXC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BXC has an improved debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.44 indicates that BXC is not in any danger for bankruptcy at the moment.
The Altman-Z score of BXC (3.44) is better than 60.42% of its industry peers.
The Debt to FCF ratio of BXC is 14.74, which is on the high side as it means it would take BXC, 14.74 years of fcf income to pay off all of its debts.
BXC has a Debt to FCF ratio of 14.74. This is comparable to the rest of the industry: BXC outperforms 54.17% of its industry peers.
A Debt/Equity ratio of 0.94 indicates that BXC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.94, BXC is doing worse than 64.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 14.74
Altman-Z 3.44
ROIC/WACC0.36
WACC9.74%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.15. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC's Current ratio of 4.15 is amongst the best of the industry. BXC outperforms 89.58% of its industry peers.
A Quick Ratio of 2.73 indicates that BXC has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.73, BXC belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.15
Quick Ratio 2.73
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -58.89% in the last year.
BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.26% yearly.
Looking at the last year, BXC shows a decrease in Revenue. The Revenue has decreased by -4.22% in the last year.
Measured over the past years, BXC shows a small growth in Revenue. The Revenue has been growing by 2.28% on average per year.
EPS 1Y (TTM)-58.89%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-87.38%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-2.34%

3.2 Future

The Earnings Per Share is expected to decrease by -11.93% on average over the next years. This is quite bad
BXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y-51.28%
EPS Next 2Y-11.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.73%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.60, BXC is valued on the expensive side.
68.75% of the companies in the same industry are more expensive than BXC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BXC to the average of the S&P500 Index (27.51), we can say BXC is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.95, BXC is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as BXC.
BXC is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.58, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.6
Fwd PE 16.95
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BXC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BXC is cheaper than 87.50% of the companies in the same industry.
BXC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BXC is cheaper than 79.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.2
EV/EBITDA 7.72
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -11.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.93%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (7/14/2025, 8:04:01 PM)

After market: 83.87 0 (0%)

83.87

-2.69 (-3.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners94.88%
Inst Owner Change0%
Ins Owners2.17%
Ins Owner Change0.53%
Market Cap672.64M
Analysts80
Price Target93.08 (10.98%)
Short Float %4.74%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.51%
Min EPS beat(2)0.88%
Max EPS beat(2)16.15%
EPS beat(4)3
Avg EPS beat(4)18.48%
Min EPS beat(4)-4.68%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)24.8%
EPS beat(12)9
Avg EPS beat(12)17.26%
EPS beat(16)13
Avg EPS beat(16)31.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-3.1%
Revenue beat(12)3
Avg Revenue beat(12)-3.04%
Revenue beat(16)7
Avg Revenue beat(16)1.85%
PT rev (1m)0%
PT rev (3m)-25.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 18.6
Fwd PE 16.95
P/S 0.23
P/FCF 16.2
P/OCF 8.2
P/B 1.06
P/tB 1.21
EV/EBITDA 7.72
EPS(TTM)4.51
EY5.38%
EPS(NY)4.95
Fwd EY5.9%
FCF(TTM)5.18
FCFY6.17%
OCF(TTM)10.22
OCFY12.19%
SpS366.02
BVpS79.3
TBVpS69.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.99%
ROCE 5.2%
ROIC 3.48%
ROICexc 5.21%
ROICexgc 5.72%
OM 2.39%
PM (TTM) 1.3%
GM 16.1%
FCFM 1.41%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.89%
ROIC(3y)11.45%
ROIC(5y)14.38%
ROICexc(3y)16.19%
ROICexc(5y)17.69%
ROICexgc(3y)17.93%
ROICexgc(5y)19.31%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.1%
ROICexcg growth 5Y30.12%
ROICexc growth 3Y-37.91%
ROICexc growth 5Y30.01%
OM growth 3Y-33.49%
OM growth 5Y28.67%
PM growth 3Y-36.23%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score4
Asset Turnover1.8
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 14.74
Debt/EBITDA 5.51
Cap/Depr 106.19%
Cap/Sales 1.38%
Interest Coverage 1.55
Cash Conversion 75.67%
Profit Quality 109.03%
Current Ratio 4.15
Quick Ratio 2.73
Altman-Z 3.44
F-Score4
WACC9.74%
ROIC/WACC0.36
Cap/Depr(3y)107.07%
Cap/Depr(5y)77.02%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.76%
Profit Quality(5y)177.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.89%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-87.38%
EPS Next Y-51.28%
EPS Next 2Y-11.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-2.34%
Revenue Next Year2.73%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.58%
EBIT growth 3Y-41.22%
EBIT growth 5Y31.61%
EBIT Next Year10.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.66%
FCF growth 3Y-29.89%
FCF growth 5YN/A
OCF growth 1Y-83.17%
OCF growth 3Y-16.31%
OCF growth 5YN/A